C. Pollock

Cost of End-of-Life Inpatient Encounters in Patients with Chronic Kidney Disease in the United States: A Report from the DISCOVER CKD Retrospective Cohort

J. Carrero, R. Pecoits-Filho, J. G. Garcia Sanchez, 2022, Advances in Therapy.

Health Care Resource Utilization and Related Costs of Patients With CKD From the United States: A Report From the DISCOVER CKD Retrospective Cohort.

J. Carrero, D. Wheeler, R. Pecoits-Filho, 2023, Kidney international reports.

Systematic review of intra‐operative duplex scanning during renal transplantation

C. Fisher, V. Puttaswamy, C. Pollock, 2022, Australasian journal of ultrasound in medicine.

Early Outcomes in Renal Transplantation With Routine Intraoperative Duplex Ultrasound.

V. Puttaswamy, C. Pollock, Jillian L. Clarke, 2023, Transplantation proceedings.

The impact of canagliflozin on the risk of neuropathy events: a post-hoc exploratory analysis of the CREDENCE trial.

B. Zinman, A. Levin, K. Mahaffey, 2022, Diabetes & metabolism.

Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial.

B. Zinman, A. Levin, K. Mahaffey, 2023, American journal of kidney diseases : the official journal of the National Kidney Foundation.

The Role of Expert Opinion in Projecting Long-Term Survival Outcomes Beyond the Horizon of a Clinical Trial

N. Tangri, D. Wheeler, C. Kovesdy, 2023, Advances in therapy.

Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering

B. Zinman, A. Levin, K. Mahaffey, 2023, BMJ Open Diabetes Research & Care.

Extremes of both weight gain and weight loss are associated with increased incidence of heart failure and cardiovascular death: evidence from the CANVAS Program and CREDENCE

K. Mahaffey, E. Ferrannini, A. Natali, 2023, Cardiovascular Diabetology.

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials

K. Mahaffey, M. Vaduganathan, A. Rodgers, 2023, Journal of the American Heart Association.

Glucose‐lowering treatment pathways of individuals with chronic kidney disease and type 2 diabetes according to the Kidney Disease: Improving Global Outcomes 2012 risk classification

J. Carrero, D. Wheeler, R. Pecoits-Filho, 2023, Diabetic medicine : a journal of the British Diabetic Association.